Status:
UNKNOWN
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Ain Shams University
Mansoura University
Conditions:
NAFLD
Insulin Resistance
Eligibility:
All Genders
18-60 years
Brief Summary
Getting a rough indicator about the prevalence of different grade of severity of NAFLD (NASH \& liver fibrosis), and Correlate the severity of fatty liver with different serological risk factors of me...
Detailed Description
This study is a prospective cross-sectional Multicenter National study, will include 1080 participants with BMI ≥ 24kg/m 2 with or without elevated liver enzymes. All will be subjected to; dietary his...
Eligibility Criteria
Inclusion
- Participants with following criteria: age: 18-60 years and both sexes
- Any participant with BMI more than or equal to 24kg/m2 (overweight and obese according to Chinese cut off values)
Exclusion
- Any hepatic diseases including e.g. Hepatitis C, Hepatitis B, autoimmune hepatitis
- Pregnant females
- Alcohol intake
- Antibiotic use within the previous 3 months
- Patients had acute or chronic health diseases.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
1080 Patients enrolled
Trial Details
Trial ID
NCT04081571
Start Date
April 1 2019
End Date
October 1 2023
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Cairo University
Cairo, Egypt